Recent TLSI Stock Price | TLSI Stock Predictions | |
$9.62 | +66.32% |
$16.00 |
Recent TLSI Analyst Ratings Breakdown, Making TLSI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the TLSI stock predictions from the analysts covering TriSalus Life Sciences Inc., we have collected all of the individual TLSI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering TLSI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TLSI stock predictions may vary widely, another useful metric to consider is the median TLSI stock prediction, which represents the price at which half of the analysts
made TLSI stock predictions that were higher and half made TLSI stock predictions that were lower. This makes for a different take on the TLSI stock predictions out there, as compared to average or mean.
And that median across all the individual TLSI stock predictions was: $16.0 as of 2024-05-07.
The very highest of the TLSI stock predictions for one year price target was $16.0, while the very lowest of the TLSI stock predictions in the analyst group was
$16.0 (with a standard deviation of $0.0). Get the latest Zacks research report on TLSI — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
TROW Stock Predictions
CAPR Stock Predictions
HBIO Stock Predictions
ALXO Stock Predictions
ESSA Stock Predictions
AVT Stock Predictions
SPOT Stock Predictions
NVDA Stock Predictions
CPK Stock Predictions
|
|
Strong Buy (4.00 out of 4) 80th percentile
(ranked higher than approx. 80% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |